Food distribution giant Sysco saw shares jump nearly 11% after reporting better-than-expected quarterly results, prompting CNBC's Jim Cramer to highlight the stock as undervalued amid a broader market rally.
CNBC's Jim Cramer voiced strong support for AstraZeneca when questioned by an investor considering a switch to AbbVie, highlighting the resilience of the pharmaceutical giant's oncology division.
Hubbell Incorporated capped off a robust 2025 with a strong fourth quarter, reporting double-digit sales and profit growth. The electrical equipment manufacturer is riding a wave of investment in grid infrastructure and data centers, positioning it for another year of solid performance in 2026.
A new Realtor.com analysis projects a turn toward balance in the housing market next year, with modest price declines expected in over twenty major metropolitan areas, offering a glimmer of relief for prospective buyers.
Medical device maker Establishment Labs Holdings Inc. (ESTA) is on a path to reach breakeven by 2027, according to analyst consensus, despite current losses and a high debt load. The company's projected growth rate highlights both its potential and the risks in the competitive aesthetics market.
In a characteristically sardonic social media post, CNBC's Jim Cramer suggested MicroStrategy's Michael Saylor should artificially boost Bitcoin's price to trigger misguided bullish signals, highlighting the tense theater surrounding the cryptocurrency's recent sharp decline.
Argentina's famed wine sector is grappling with a profound crisis, marked by plummeting domestic sales, declining exports, and financial distress among historic wineries, as shifting global habits and economic pressures converge.
Federal Reserve Governor Stephen Miran, a recent dissenter in FOMC policy votes, publicly argues for interest rate reductions exceeding one percentage point in 2024, citing flawed inflation metrics and potential harm to the labor market.
Nio shares fell sharply after January deliveries showed a steep sequential drop, overshadowing near-doubled year-over-year growth. Analysts argue the sell-off presents a buying opportunity, citing improving margins, a multi-brand strategy, and a discounted valuation.
New research reveals that prices at ambulatory surgery centers acquired by Optum rose by an average of 11%, potentially adding over $67 million annually to costs in affected markets, fueling the debate on healthcare consolidation.
In a competitive labor market, companies are re-evaluating their total compensation strategies. A new report breaks down the distinct roles of foundational benefits, cultural perks, and performance-based rewards in driving engagement and retention.
As Josh D'Amaro prepares to succeed Bob Iger on March 18, the incoming CEO's deliberate choice to live near Disneyland rather than in Los Angeles reflects a leadership style deeply embedded in the company's core experiences business, amid high expectations and scrutiny.
Industrial conglomerate Illinois Tool Works reports robust Q4 earnings, outperforming end markets with disciplined execution and strategic focus on customer-backed innovation. The company sets a confident tone for 2026, forecasting continued margin expansion and organic growth.
Following its success in Ontario, PointsBet has secured regulatory approval to launch its sportsbook and iGaming platform in Alberta, marking a significant step in the province's move toward a competitive, regulated online betting market.
As Palantir Technologies' stock soars, fueled by robust government and commercial demand, we examine the key drivers behind its growth and the high-stakes valuation debate.
Two full casks of the legendary and discontinued Karuizawa whisky, distilled in 1999, are set for a landmark sale at Christie's, with experts predicting a record-breaking seven-figure sum.
Amid persistent inflation, New York's Division of Consumer Protection has published a comprehensive guide to help residents cut expenses on essentials from groceries to utilities, emphasizing that strategic, small changes can yield significant financial relief.
Cimpress (CMPR) stock reached a new 52-week peak, buoyed by robust technical indicators and a perfect 'Buy' rating from Barchart. While analyst targets vary widely, the company's momentum and valuation in the printing and design sector are drawing investor attention.
In a significant push to expand domestic defense manufacturing, the Pentagon has finalized agreements with Lockheed Martin and L3Harris Technologies to dramatically accelerate production of key missile systems like THAAD and PAC-3 interceptors, part of a broader strategy to fortify the U.S. industrial base amid global tensions.
As Bitcoin tests key price levels, analysts identify $60,000-$68,000 as a potential accumulation zone for long-term holders, suggesting the current downturn may be approaching its final stages absent a broader market collapse.
